AbbVie (ABBV) Income After Tax (2012 - 2026)
AbbVie (ABBV) recorded Income After Tax of $4.22 billion in Q3 2026, compared with $188 million a year earlier and up 16.7% from the prior quarter.
AbbVie (ABBV) Income After Tax (2012 - 2026) Analysis & Trends
On a TTM basis, AbbVie's Income After Tax came in at $10.35 billion as of Sep 30, 2026, up 332.1% year-over-year; for FY2025, it came in at $4.23 billion, down 1.2% from FY2024.
- Annual Income After Tax has declined for three straight years, with a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- Across earlier years, Income After Tax came in at $4.29 billion in FY2024 (-12.0%), $4.87 billion in FY2023 (-58.9%), $11.85 billion in FY2022 (+2.6%) and $11.55 billion in FY2021 (+149.9%).
- The Q3 2026 figure is the highest quarterly Income After Tax since Q1 2022.
- On a year-over-year basis, Income After Tax rose in 1 of the last five quarters, with growth averaging 22.6%.
- Peak year-over-year performance for Income After Tax in the last five years was growth of 284.3% in Q2 2026, against a decline of 89.4% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.62 billion (Q2 2026), $697 million (Q1 2026) and $1.82 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,286.35 Bn | 1,259.96 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 655.58 Bn | 575.44 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 509.44 Bn | 477.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.14 Bn | 325.14 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 309.04 Bn | 282.62 Bn | - | - |
| 6 | Astrazeneca | 289.57 Bn | 263.55 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 248.97 Bn | 200.62 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.95 Bn | 182.98 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 170.25 Bn | 117.91 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Vertex Pharmaceuticals | 137.54 Bn | 109.53 Bn | 2.91 Bn | 653.60 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.22 Bn |
| Jun 30, 2026 | 3.62 Bn |
| Mar 31, 2026 | 697.00 Mn |
| Dec 31, 2025 | 1.82 Bn |
| Sep 30, 2025 | 188.00 Mn |
| Jun 30, 2025 | 941.00 Mn |
| Mar 31, 2025 | 1.29 Bn |
| Dec 31, 2024 | -23.00 Mn |
| Sep 30, 2024 | 1.56 Bn |
| Jun 30, 2024 | 1.37 Bn |
| Mar 31, 2024 | 1.37 Bn |
| Dec 31, 2023 | 824.00 Mn |
| Sep 30, 2023 | 1.78 Bn |
| Jun 30, 2023 | 2.03 Bn |
| Mar 31, 2023 | 475.00 Mn |
| Dec 31, 2022 | 2.47 Bn |
| Sep 30, 2022 | 3.95 Bn |
| Jun 30, 2022 | 928.00 Mn |
| Mar 31, 2022 | 4.49 Bn |
| Dec 31, 2021 | 4.05 Bn |
AbbVie Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ABBV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();